Table 2

Risk of IS and MI in relation to VWF and ADAMTS13 plasma levels

Controls, nIS
MI
Cases, nOR1 (95% CI)OR2 (95% CI)Cases, nOR1 (95% CI)OR2 (95% CI)
VWF Q1 156 13 1 (ref) 1 (ref) 20 1 (ref) 1 (ref) 
VWF Q2 157 22 1.4 (0.7-3.1) 1.6 (0.7-3.6) 35 1.6 (0.9-3.0) 1.7 (0.9-3.4) 
VWF Q3 157 50 3.8 (1.9-7.6) 4.2 (2.0-9.0) 60 2.5 (1.4-4.5) 3.1 (1.6-5.9) 
VWF Q4 156 82 5.9 (3.0-11.7) 6.7 (3.2-13.8) 87 3.7 (2.1-6.5) 4.2 (2.2-8.0) 
ADAMTS13 Q1 156 61 3.1 (1.8-5.5) 3.1 (1.6-5.8) 63 1.8 (1.1-3.0) 1.4 (0.8-2.4) 
ADAMTS13 Q2 157 45 2.4 (1.4-4.4) 3.0 (1.6-5.7) 50 1.2 (0.8-2.0) 0.9 (0.5-1.6) 
ADAMTS13 Q3 157 33 1.5 (0.8-2.7) 1.7 (0.9-3.3) 44 1.0 (0.6-1.7) 0.8 (0.5-1.5) 
ADAMTS13 Q4 156 28 1 (ref) 1 (ref) 45 1 (ref) 1 (ref) 
Controls, nIS
MI
Cases, nOR1 (95% CI)OR2 (95% CI)Cases, nOR1 (95% CI)OR2 (95% CI)
VWF Q1 156 13 1 (ref) 1 (ref) 20 1 (ref) 1 (ref) 
VWF Q2 157 22 1.4 (0.7-3.1) 1.6 (0.7-3.6) 35 1.6 (0.9-3.0) 1.7 (0.9-3.4) 
VWF Q3 157 50 3.8 (1.9-7.6) 4.2 (2.0-9.0) 60 2.5 (1.4-4.5) 3.1 (1.6-5.9) 
VWF Q4 156 82 5.9 (3.0-11.7) 6.7 (3.2-13.8) 87 3.7 (2.1-6.5) 4.2 (2.2-8.0) 
ADAMTS13 Q1 156 61 3.1 (1.8-5.5) 3.1 (1.6-5.8) 63 1.8 (1.1-3.0) 1.4 (0.8-2.4) 
ADAMTS13 Q2 157 45 2.4 (1.4-4.4) 3.0 (1.6-5.7) 50 1.2 (0.8-2.0) 0.9 (0.5-1.6) 
ADAMTS13 Q3 157 33 1.5 (0.8-2.7) 1.7 (0.9-3.3) 44 1.0 (0.6-1.7) 0.8 (0.5-1.5) 
ADAMTS13 Q4 156 28 1 (ref) 1 (ref) 45 1 (ref) 1 (ref) 

ORs were calculated by logistic regression and were adjusted for age, year of event/index year, and area of residence. OR2 values were also adjusted for hypercholesterolemia, hypertension, diabetes mellitus, and smoking.

Q indicates quartile; and ref, reference.

Close Modal

or Create an Account

Close Modal
Close Modal